中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 12
Dec.  2013
Turn off MathJax
Article Contents

Update on diagnosis and treatment of Wilson disease in China

DOI: 10.3969/j.issn.1001-5256.2013.12.008
  • Received Date: 2013-08-27
  • Published Date: 2013-12-20
  • Wilson disease ( WD) is a rare and treatable genetic disease that is found worldwide. The latest progress and author's experience in this field are described, and some notable clinical issues concerning this disease in China are discussed. Many studies have shown that in recent years, the number and age range of WD cases have increased, and more and more liver-type and atypical cases have been identified; WD is difficult to diagnose, and misdiagnosed cases are commonly seen. Heightened alertness is the key to the prevention of misdiagnosis, and laboratory testing is an indispensible basis for diagnosis of this disease. Kayser-Fleischer ring, ceruloplasmin, urinary copper, hepatic copper, and genetic testing are of great significance for the diagnosis of WD. Hepatic copper has the highest specificity and sensitivity for WD, reaching 95%, and genetic testing has a specificity of 100% and a sensitivity of 60%-85% for WD. Patients suspected of WD should undergo systemic copper metabolic examination. Diagnostic criteria should be strictly followed, and WD can be diagnosed if the total score is not lower than 4; diagnosis cannot be based on a single test. Once the diagnosis is confirmed, therapy is started regardless of the severity of disease. Severe cases are not encouraged to discontinue therapy due to the side effects of drugs. Fulminating cases should receive rapid decopper treatment as soon as possible. Liver transplantation may be considered for patients with acute or chronic liver failure unresponsive to medical therapy. Overall, patients who receive adequate care for WD have a good long-term prognosis. We need to recognize the new characteristics of this disease and improve the diagnosis and treatment of WD in China.

     

  • loading
  • [1]THOMAS GR, FORBES JR, ROBERTS EA, et al.The Wilson disease gene:spectrum of mutations and their consequences[J].Nat Genet, 1995, 9 (2) :210-217.
    [2]European Association for the Study of the Liver.EASL clinical practice guidelines:Wilson’s disease[J].J Hepatol, 2012, 56 (3) :671-685.
    [3]ROBERTS EA, SCHILSKY MI.Diagnosis and treatment of Wilson disease:an update[J].Hepatology, 2008, 47 (6) :2089-2111.
    [4]ROBERTS EA.“Not so rare”Wilson disease[J].Clin Res Hepatol Gastroenterol, 2013, 37 (3) :219-221.
    [5]PRASHANTH LK, TALY AB, SINHA S, et al.Wilson’s disease:diagnostic errors and clinical implications[J].J Neurol Neurosurg Psychiatry, 2004, 75 (6) :907-909.
    [6]WALSHE JM, YEALLAND M.Not Wilson’s disease:a review of misdiagnosed cases[J].QJM, 1995, 88 (1) :55-59.
    [7]ALA A, BORJIGIN J, ROCHWARGER A, et al.Wilson disease in septuagenarian siblings:raising the bar for diagnosis[J].Hepatology, 2005, 41 (3) :668-670.
    [8]FERENCI P, CZTONKOWSKA A, MERLE U, et al.Late-onset Wilson’s disease[J].Gastroenterology, 2007, 132 (4) :1294-1298.
    [9]STEINDL P, FERENCI P, DIENES HP, et al.Wilson’s disease in patients presenting with liver disease:a diagnostic challenge[J].Gastroenterology, 1997, 113 (1) :212-218.
    [10]YANG X, TONG DJ, LIANG J, et al.Ceruloplasmin level of patients with liver disease in China[J].Chin J Intern Med, 2005, 44 (1) :13-15. (in Chinese) 杨旭, 童德军, 梁骏, 等.中国肝病患者血清铜蓝蛋白水平的研究[J].中华内科杂志, 2005, 44 (1) :13-15.
    [11]FERENCI P, STEINDL P, GOGEL W, et al.Diagnostic value of quantitative hepatic copper determination in patients with Wilson’s disease[J].Clin Gastroenterol Hepatol, 2005, 3 (8) :811-816.
    [12]SCHILSKY ML.Wilson disease:current status and the future[J].Biochimie, 2009, 91 (10) :1278-1281.
    [13]LUO KZ, YANG X, TONG DJ, et al.Direct sequencing and analysis of exone of Wilson’s disease gene with the most mutations:a study in Hunan Han patients[J].Chin J Hepatol, 2006, 14 (12) :920-923. (in Chinese) 罗开忠, 杨旭, 童德军, 等.湖南地区肝豆状核变性基因突变热区的序列检查与分析[J].中华肝脏病杂志, 2006, 14 (12) :920-923.
    [14]WONG RJ, GISH R, SCHILSKY M, et al.A clinical assessment of Wilson disease in patients with concurrent liver disease[J].J Clin Gastroenteology, 2011, 45 (3) :1267-1273.
    [15]BREWER GJ.Wilson’s disease:a clinican’s guide to recognition, diagnosis, and managemenet[M].Boston:Kluwer Academic Publeishers, 2001.
    [16]FERENCI P, CACA K, LOUDIANOS G, et al.Diagnosis and phenotypic classification of Wilson disease[J].Liver Int, 2003, 23 (3) :139-142.
    [17]MERLE U, SCHAEFER M, FERENCI P, et al.Clinical presentation, diagnosis and ling-term outcome of Wilson’s disease:a cohort study[J].Gut, 2007, 56 (1) :115-120.
    [18]BRUHA R, MARECEK Z, POSPISILOVA L, et al.Long-term follow-up of Wilson disease:natural history, treatment, mutations analysis and phenotypic correlation[J].Liver Int, 2011, 31 (1) :83-91.
    [19]LUO HY, YANG X, ZHANG YH, et al.Clinical analysis of 13WD patients with fulminant liver failure[J].Chin J Intern Med, 2006, 45 (12) :1020-1021. (in Chinese) 罗红雨, 杨旭, 张永红, 等.暴发性肝衰竭型肝豆状核变性13例临床分析[J].中华内科杂志, 2006, 45 (12) :1020-1021.
    [20]TIAN Y, GONG GZ, YANG X.Prognosis and treatment of fulminant Wilson’s disease[J].J Cent South Univ:Med Sci, 2011, 36 (11) :1111-1114. (in Chinese) 田沂, 龚国忠, 杨旭.暴发型肝豆状核变性的治疗及预后分析[J].中南大学学报:医学版, 2011, 36 (11) :1111-1114.
    [21]YANG X.Wilson disease[M].Changsha:Central South University Press, 2006. (in Chinese) 杨旭.肝豆状核变性[M].长沙:中南大学出版社, 2006.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (215) PDF downloads(217) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return